Albert Cha, Director at KalVista Pharmaceuticals, Inc. (KALV), bought 1,058,824 shares at $17.00 ($18.0M) on 2018-09-10, disclosed to the SEC on 2018-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| KALV | BUY | 2019-07-30 | $1.9M | — | Filing → |
| KALV | BUY | 2019-07-19 | $2.2M | — | Filing → |
| MNLO | BUY | 2018-01-29 | $5.0M | — | Filing → |